Advertisement

Irish Journal of Medical Science

, Volume 151, Issue 1, pp 61–70 | Cite as

Pharmacology and clinical use of antiandrogens: A short review

  • Friedmund Neumann
Article

Keywords

Androgen Sebaceous Gland Flutamide IRISH Journal Cyproterone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adachi, K., Takayasu, S. 1972. The mechanism of testosterone action of the sebaceous glands of the Syrian hamster. In: “Advances in Biology of Skin”, vol. XII“Pharmacology and the Skin”, p. 381. Eds : W. Montagna, E. J. van Scott and R. Stoughton. Appleton Century Crofts Educational Division, Meredit Corporation, New York.Google Scholar
  2. Aydinlik, S., Lachnit-Fixson, U. 1977. Diane-eine Gestagen-östrogenkombination mit Antiandrog- enwirkung. Med. Mtonatsschr. 31, 425–429.Google Scholar
  3. Baulieu, E. E., Jung, I. 1970. A prostatic cytosol receptor. Biochem. Biophys. Res. Commun. 38, 599–606.PubMedCrossRefGoogle Scholar
  4. Beach, F. A., Westbrook, W. H. 1968. Morphological and behavioural effects of an ‘antiandrogen’ in male rats. J. Endocrinol. 42, 379–882.PubMedGoogle Scholar
  5. Belham, J. E., Neal, G. E., Williams, D. 1969 a. The reception of androgens in the rat ventral prostate. Biochem. J. 114, 32P.Google Scholar
  6. Belham, J. E., Neal, G. E., Williams, D. 1969 b. Testosterone metabolism in the rat ventral prostate. Biochim. Biophys. Acta 187, 159–162.PubMedGoogle Scholar
  7. Beyer, J., Demisch, K., Wiegelmann, W., Happ, J., Kollmann, F., Schöffling, 1973. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta Endocrinol. (Copenhagen) Suppl. 173, 169.Google Scholar
  8. Bossi, E., Joss, E. E., Zurbrugg, R. P. 1973 a. Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Acta Paediat. Scand. 62, 401–404.PubMedCrossRefGoogle Scholar
  9. Bossi, E., Zurbrügg, R. P. 1973. Behandlung der Pubertas praecox mit dem Antiandrogen Cyproteronacetat. Klin. Wochenschr. 51, 774.Google Scholar
  10. Bossi, E., Zurbrugg, R. P., Joss, E. E. 1973 b. Improvement of adult height prognosis in precocious puberty by cyproterone acetate. Acta Paediat. Scand. 62, 405–412.PubMedCrossRefGoogle Scholar
  11. Bracci, U., di Silverio, F. 1972. Present procedure with regard to the use of hormone therapy in cases of cancer of the prostate. In: Proceedings of the 18th World Congress Int. College of Surgeons, Rome 1972, pp. 275–276. ICS 29. Eds.: P. Steffanini and V. Speranza. Excerpta Medica, Amsterdam.Google Scholar
  12. Braendle, W., Boess, H., Breckwoldt, M., Leven, Ch., Bettendorf, G. 1974. Wirkung und Nebenwirkung der Cyproteronacetatbehandlung. Arch. Gynaekol. 216, 335–345.CrossRefGoogle Scholar
  13. ]Dorfman, R. I. 1962. Anti-androgenic substances. In:“Methods in Hormone Research”, vol. II, chapt. 7, pp. 315–323. Ed.: R. I. Dorfman. Academic Press, New York, London.Google Scholar
  14. Dorfman, R. I. 1964. Antiandrogenis, antiestrogenic and antiovulatory compounds. In:“Hormonal Steroids. Biochemistry, Pharmacology and Therapeutics”, vol 1, p. 39–50. Eds.: L. Martini and A. Pecile. Academic Press, New York, London.Google Scholar
  15. Dorfman, R. I. 1970. Biological activity of anti- androgens. Brit. J. Dermatol. 82, Suppl. 6, 3–8.CrossRefGoogle Scholar
  16. Ebling, F. J. 1957 a. The action of testosterone and oestradiol on the sebaceous glands and epidermis of the rat. J. Embryol. Exp. Morphol. 5, 74–82.Google Scholar
  17. Ebling, F. J. 1957 b. The action of testosterone on the sebaceous glands and epidermis in castrated and hypophysectomized male rats. J. Endocrinol 15, 297–306.PubMedGoogle Scholar
  18. Ebling, F. J. 1970. Factors influencing the response to the sebaceous glands of the rat to androgen. Brit. J. Dermatol. 82, Suppl. 6, 9–14.CrossRefGoogle Scholar
  19. Ebling, F. J. 1973. The effects of cyproterone acetate and oestradiol upon testosterone stimulated sebaceous activity in the rat. Acta Endocrinol. (Copenhagen) 72, 361–365.Google Scholar
  20. Ebling, F. J. 1974. Hormonal control and methods of measuring sebaceous gland activity. J. Invest. Dermatol 62, 161–171.PubMedCrossRefGoogle Scholar
  21. Ebling, F. J., Skinner, J. 1967. The measurement of sebum production in rats treated with testosterone and oestradiol. Brit. J. Dermatol. 79, 386–393.CrossRefGoogle Scholar
  22. EIger, W. 1966. Die Rolle der fetalen Androgene in der Sexualdifferenzierung des Kaninchens und ihre Abgrenzung gegen andere hormonale und somatische Faktoren durch Anwendung eines starken Antiandrogens. Arch. Anat. Microsc. Morphol. Exp. 55, 657–743.Google Scholar
  23. Fang, S., Anderson, K. M., Liao, S. 1969. Receptor proteins for androgens. On the role of specific proteins in selective retention of 17β-hydroxy- 5α-androstan-3-one by rat ventral prostate in vivo and in vitro. J. Biol. Chem. 244, 6584–6595.PubMedGoogle Scholar
  24. Fang, S., Liao, S. 1969. Antagonistic action of antiandrogens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Mol. Pharmacol. 5, 428–431.PubMedGoogle Scholar
  25. Fang, S., Liao, S. 1971. Androgen receptors. Steroid- and tissue-specific retention of a 17β-hydroxy-5α-androstan-3-one protein complex by the cell nuclei of ventral prostate. J. Biol. Chem. 246, 16–24.PubMedGoogle Scholar
  26. Geller, J., Baron, A., Fishman, J. 1971. Effects of cyprO’terone acetate on pituitary and gonadal function in elderly males. Clin. Res. 19, 171.Google Scholar
  27. Geller, J., Fruchtman, B., Meyer, C., Newman, H. 1967. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J. Clin. Endocrinol. Metab. 27, 556–560.PubMedCrossRefGoogle Scholar
  28. Geller, J., McCoy, K. 1972. Correlation of biologic and biochemical effects of antiandrogens on rat ventral prostate. Clin. Res. 20, 177.Google Scholar
  29. de Graaf, H. J. 1943. The effect of sex hormones on sebaceous glands. Ned. Tijdschr. Geneesk. 87, 1450.Google Scholar
  30. Graf, K.-J., Brotherton, J., Neumann, F. 1974. Clinical uses of antiandrogens (other than for hyper-sexuality and sexual deviations). In: “Handbook of Experimental Pharmacology”, vol. 35/2, chapt. 7, pp. 485–542. Eds.: O. Eichler, A. Farah, H. Herken and A. D. Welch. Springer-Verlag, Berlin, Heidelberg, New York.Google Scholar
  31. Hamada, H., Neumann, F., Junkmann, K. 1963. Intrauterine antimaskuline Beeinflussung von Rattenfeten durch ein stark gestagen wirksames Steroid. Acta Endocrinol. (Copenhagen) 44, 380–388.Google Scholar
  32. Hammerstein, J., Cupceancu, B. 1969. Behandlung des Hirsutismus mit Cyproteronacetat. Deut. Med. Wochenschr. 94, 829–834.Google Scholar
  33. Haskin, D., Lasher, N., Rothman, S. 1953. Some effects of ACTH, cortisone, progesterone and testosterone on sebaceous glands in white rat. J. Invest. Dermatol. 20, 207–212.PubMedGoogle Scholar
  34. Helige, H. 1973. Fruhreife. Monatsschr. Kinderheilk. 121, 636–646.Google Scholar
  35. Hertel, P., Kramer, M., Neumann, F. 1969. Ein- fluβ eines Antiandrogens (Cyproteronacetat) auf Knochenwachstum und Knochenreifung mannlicher Ratten. Arzneim. Forsch. 19, 1777–1790.Google Scholar
  36. Jacobi, G. H., Senge, Th., Ackermann, R. 1980. Wissenschaftliche Ausstellung Nr. 11, XXXII. Kongress Deutsch. Gesellsch. Urol., Berlin, September 10–13.Google Scholar
  37. Jung, I, Baulieu, E. E. 1971. Neo-nuclear androgen receptor in rat ventral prostate. Biochimie 53, 807–817.PubMedCrossRefGoogle Scholar
  38. Lapière, C., Chevremont, M. 1953. Modifications des glandes sebacees par des hormones sexuelles appliquees localement sur la peau de Souris. CR. Soc. Biol. 147, 1302–1306.Google Scholar
  39. Lerner, L. J. 1964. Hormone antagonists: inhibitors of specific activities of estrogen and androgen. Recent Progr. Horm. Res. 20, 435–490.PubMedGoogle Scholar
  40. Mauermayer, W. 1971. Cyproterone therapy in prostatic cancer stage IV. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, pp. 179–180. (Life Sciences Monographs 1). Eds.: G. Raspé and W. Brosig. Pergamon Press, Vieweg, Oxford, Edinburgh, New York.Google Scholar
  41. Mellin, P. 1971. Cyproterone therapy in prostatic cancer stage IV. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, p. 180. (Life Sciences Monographs 1). Ed.: G. Raspé and W. Brosig. Pergamon Press, Vieweg, Oxford, Edinburgh, New York.Google Scholar
  42. Montagna, W., Kenyon, P. 1949. Growth potentials and mitotic division in sebaceous glands of the rabbit. Anat. Ree. 103, 365–379.CrossRefGoogle Scholar
  43. Morse, H. C., Leach, D. R., Rowley, M. J., Heller, C. G. 1973. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J. Reprod. Feit. 32, 365–378.CrossRefGoogle Scholar
  44. Neumann, F. 1977. Probleme der Dosisfindung: Sexualhormone. Arzneim. Forsch. 27, 296–318.Google Scholar
  45. Neumann, F. 1979. Antiandrogene—Grundlagen und experimentelle Befunde an der Haut. In: “Haar und Haarkrankheiten”, Kapitel 40, S. 961–1009. C. E. Orfanos (Hrsgb.). Gustav Fischer Verlag, Stuttgart, New York.Google Scholar
  46. Neumann, F., von Berswordt-Wallrabe, R., Elger, W., Steinbeck, H., Hahn, J. D., Kramer, M. 1970 a. Aspects of androgen-dependent events as studied by antiandrogens. Laurentian Hormone Conference, Mont Tremblant / Canada 1969. Recent. Progr. Horm. Res. 26, 337–410.PubMedGoogle Scholar
  47. Neumann, F., Diallo, F. A., Hasan, S. H., Schenck, B., Traoré, I. 1976. The influence of pharmaceutical compounds on male fertility. Andrologie 8, 203–235.Google Scholar
  48. Neumann, F., Elger, W., Steinbeck, H. 1970 b. Antiandrogens and reproductive development. Phil. Trans. Roy. Soc. London Ser. B. 259, 179–184.CrossRefGoogle Scholar
  49. Neumann, F., Elger, W., Steinbeck, H., von Berswordt-Wallrabe, R. 1967. Antiandrogene. In: “Das Testosteron—die Struma”, pp. 78–101. Ed.: E. Klein. Springer-Verlag, Berlin, Heidelberg, New York.Google Scholar
  50. Neumann, F., Gräf, K.-J., Hasan, S. H., Schenck, B., Steinbeck, H. 1977. Central actions of antiandrogens. In:“Anrogens and Antiandrogens”, pp. 163–177. Eds.: L. Martini and M. Motta, Raven Press, New York.Google Scholar
  51. Neumann, F., Hamada, H. 1964. Intrauterine Feminisierung männlicher Rattenfeten durch das stark gestagen wirksame e-chlor-6-methylen- 17αhydroxy-progesteronacetat. 10. Symposium der Deutschen Gesellschaft fur Endokrinologie, Wien 1963, S. 301–304. Springer-Verlag, Berlin, Heidelberg, New York.Google Scholar
  52. Neumann, F., Steinbeck, H. 1974. Antiandrogens. In:“Handbook of Experimental Pharmacology”, vol. 35/2, chapt. 6, pp. 235–484. Eds.: O. Eichler, A. Farah, H. Herken and A. D. Welch. Springer- Verlag, Berlin, Heidelberg, New York.Google Scholar
  53. Ott, F. 1968. Hypersexualitat, Antiandrogene und Hodenfunktion. Praxis 57, 218–220.PubMedGoogle Scholar
  54. Ott, F. Hoffet, H. 1968. Beeinflussung von Libido, Potenz und Hodenfunktion durch Antiandro- gene. Schweiz. Med. Wochenschr. 98, 1812–1815.PubMedGoogle Scholar
  55. Schenck, B., Neumann, F. 1973. Einfluβ von Sexualhormonen auf Knochenreifung und Knochenwachstum weiblicher Ratten. Arzneim Forsch. 23, 887–907.Google Scholar
  56. Schindler, A. E. 1977. Behandlung mit Antiandrogenen in der Gynakologie Deut. Med. Wochenschr. 102, 763–765.CrossRefGoogle Scholar
  57. Scott, W. W. 1971. Cyproterone acetate treatment of disseminated prostatic cancer and benign nodular hyperplasia. In:“International Symposium on the Treatment of Carcinoma of the Prostate”, Berlin 1969, pp. 161–163. (Life Sciences Monographs 1). Eds.: G. Raspé and W. Brosig. Pergamon Press - Vieweg, Oxford, Edinburgh, New York.Google Scholar
  58. Smith, R. B., Walsh, P. C., Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J. Urol. 110, 106–108.PubMedGoogle Scholar
  59. Steinbeck, H., Neumann, F. 1971. Effect of cyproterone acetate on puberty. J. Reprod. Fert. 26, 59–63.CrossRefGoogle Scholar
  60. Trolp, R., Breckwoldt, M., Rachel, F., Braendle, W. 1979. Probleme der Antiandrogenbehand-lung. Gynaekol. Prax. 3, 73–78.Google Scholar
  61. Wein, A. J., Murphy, J. J. 1973. Experience in the treatment of prostatic carcinoma with cyproterone acetate. J. Urol. 109, 68–70.PubMedGoogle Scholar
  62. Wendt, H., Hummelinck, R. 1980. The effect of cyproterone acetate on some endocrinological parameters. In: Androgenization in Women— Acne, Seborrhoen, Androgenetic Alopecia and Hirsutism”, pp. 259–265. Eds.: J. Hammerstein, U. Lachnit-Fixson, F. Neumann and G. Plewig. Excerpta Medica, Amsterdam, Oxford, Princeton.Google Scholar
  63. Wiechert, R., Neumann, F. 1965. Gestagene Wirksamkeit von 1-Methyl- und 1,2α-Methylen- Steroiden. IV. Mitteilung: 1-Methyl-Steroide. Arzneim. Forsch. 15, 244–246.Google Scholar

Copyright information

© Springer 1982

Authors and Affiliations

  • Friedmund Neumann
    • 1
    • 2
  1. 1.Research Laboratories of Schering AGBerlin West and BergkmenFederal Republic of Germany
  2. 2.Department of Endocrine PharmacologyBerlin 65

Personalised recommendations